CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW


TWO TECHNOLOGIES

ONE OBJECTIVE


To convert cancer and other degenerative diseases into non-lethal manageable conditions


Dr Graham Kelly, Executive Chairman

CLICK HERE TO READ THE 2014 AGM PRESENTATION

CLICK HERE TO READ THE 2014 AGM PRESENTATION

CLICK HERE TO READ THE CEO REPORT ON AGM AND THE FUTURE

CLICK HERE TO READ THE CEO REPORT ON AGM AND THE FUTURE

 

RESOURCES

All the Latest News >         STOP PRESS

Message From the CEO HERE

Novogen Identifies Lead ATM Drug Candidate  HERE

CEO Report on AGM and the Future HERE

2014 AGM Presentation HERE

Results of 2014 AGM  HERE

AGM - Chairman's Address HERE

Cantrixil Highly Effective In Ovarian Test HERE

You Can View the Recorded Webinar  HERE

CEO Interview with ShareCafe  HERE

 

CONTACT DETAILS

 

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group

Graham.Kelly@novogen.com
+(61 2) 9472 4100

 

Media Enquiries
Cristyn Humphreys
Operations Manager Novogen Group

Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111 / + 61 499 088 482